期刊文献+

Tim-3和PD-1在慢性丙型肝炎患者不同单核细胞亚群的表达水平分析 被引量:7

Changes of Tim-3 and PD-1 on peripheral blood monocyte subsets in patients with chronic hepatitis C
下载PDF
导出
摘要 目的分析慢性丙型肝炎(CHC)患者外周血单核细胞亚群分布,同时观察负性调节分子T细胞免疫球蛋白及黏蛋白域蛋白3(Tim-3)和程序性细胞死亡蛋白1(PD-1)在各亚群表达的变化及意义。方法利用流式细胞术检测CHC患者外周血单核细胞亚群比例和各亚群Tim-3、PD-1表达,并与临床指标如丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)采用Spearman方法进行相关性分析。结果与健康对照组比较,CHC患者外周血CD14^+CD16^+单核细胞比例增高,以CD14CD16^+单核细胞比例增高显著。Tim-3在CD14CD16-单核细胞和CD14^+CD16单核细胞上表达水平升高;PD-1在CD14CD16-单核细胞和CD14CD16^+单核细胞上表达水平升高。CHC患者单核细胞亚群以及各亚群Tim-3、PD-1和临床指标ALT及AST无明显相关性。结论 Tim-3和PD-1在不同单核细胞亚群表达水平不同。 Objective To investigate the distribution of peripheral blood monocyte subsets of chronic hepatitis C (CHC) patients and observe the expression of negative regulators T cell immunoglobulin and mucin domain-3 (Tim-3) and programmed cell death-1 (PD-1) on the monocyte subsets. Methods Flow cytometry was employed to determine the distribution of three monocyte subsets as well as Tim-3 and PD-1 expression on the three monocyte subsets. Their correlations with the clinical parameters were analyzed by Spearman test. Results Compared with healthy controls, an increased distribution of CD14+ CD16+monocytes, especially CDI4++ CD16+ monocyte subset, was observed in CHC patients. Tim-3 expression was significantly elevated on CD14++CD16+ and CDI4 + CD16++ subsets in CHC patients. Obviously increased PD-1 expression was found mainly on CD14++ CD16+and CD14++ CD16+ subsets. There were no significant correlations between monocyte subsets, PD-1, Tim-3 and the clinical parameters. Conclusion The levels Tim-3 and PD-1 are different in three monocyte subsets.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2016年第5期666-670,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金面上项目(81270499)
关键词 慢性丙型肝炎 单核细胞亚群 T细胞免疫球蛋白及黏蛋白域蛋白3(Tim-3) 程序性细胞死亡蛋白1(PD-1) chronic hepatitis C monocyte subsets T cell immunoglobulin and mucin domain-3 (Tim-3) programmed cell death-1 (PD-1)
  • 相关文献

参考文献2

二级参考文献40

  • 1Seeff LB.Natural history of chronic hepatitis C[].Hepatology.2002
  • 2Daniela C. Kroy,Donatella Ciuffreda,Jennifer H. Cooperrider,Michelle Tomlinson,Garrett D. Hauck,Jasneet Aneja,Christoph Berger,David Wolski,Mary Carrington,E. John Wherry,Raymond T. Chung,Kenneth K. Tanabe,Nahel Elias,Gordon J. Freeman,Rosemarie H. de Kruyff,Joseph Misdraji,Arthur Y. Kim,Georg M. Lauer.Liver Environment and HCV Replication Affect Human T-Cell Phenotype and Expression of Inhibitory Receptors[J]. Gastroenterology . 2014 (2)
  • 3Brian T.Fife,Kristen E.Pauken.The role of the PD‐1 pathway in autoimmunity and peripheral tolerance[J]. Annals of the New York Academy of Sciences . 2011 (1)
  • 4Mohamed L. Salem,Maha EL-Demellawy,Abdel Raouf Abou El-Azm.The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus[J]. Cellular Immunology . 2010 (2)
  • 5Loise M.Francisco,Peter T.Sage,Arlene H.Sharpe.The PD‐1 pathway in tolerance and autoimmunity[J]. Immunological Reviews . 2010 (1)
  • 6Yin Wen,Lei Ying feng,Yang Jing,Lu Xin,Xu Zhikai.Controlling hepatitis C with immunotherapy[J]. The Lancet Infectious Diseases . 2009 (11)
  • 7Nobuhiro Nakamoto,David E. Kaplan,Jennifer Coleclough,Yun Li,Mary E. Valiga,Mary Kaminski,Abraham Shaked,Kim Olthoff,Emma Gostick,David A. Price,Gordon J. Freeman,E. John Wherry,Kyong–Mi Chang.Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization[J]. Gastroenterology . 2008 (7)
  • 8Christoph S. Klade,Heiner Wedemeyer,Thomas Berg,Holger Hinrichsen,Grazyna Cholewinska,Stefan Zeuzem,Hubert Blum,Michael Buschle,Sandra Jelovcan,Vera Buerger,Erich Tauber,Juergen Frisch,Michael P. Manns.Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41[J]. Gastroenterology . 2008 (5)
  • 9Taku Okazaki,Tasuku Honjo.The PD-1–PD-L pathway in immunological tolerance[J]. Trends in Immunology . 2006 (4)
  • 10James L. Riley,Carl H. June.The road to recovery: translating PD-1 biology into clinical benefit[J]. Trends in Immunology . 2006 (2)

共引文献10

同被引文献101

  • 1Shasha D, Walker B D. Lessons to be learned from natural control ofHIV - Future directions, therapeutic, and preventive implications[J/OL]. Front Immunol, 2013,4: 162. doi: 10. 3389/fimmu.2013.00162. eCollection 2013.
  • 2Rasheed M, Bettad^iura R, Bajaj C. X-ray, Cryo-EM, and coirfRitationallypredicted protein structures used in integrative modeling of HIV Envglycoprotein gpl20 in complex with CD4 and 17b [ J]. Data Brief,2016,6: 833 -839.
  • 3Harrison S C. Viral membrane fusion [ J]. Nat Struct Mol Biol,2008,15(7): 690 - 698.
  • 4Barnett D, Walker B, Landay A, et al. CD4 immunophenotyping inHIV infection[J]. Nat Rev Microbiol, 2008, 6(11) : S7 -S15.
  • 5Ford E S, Puronen C E, Sereti I. Immunopathogenesis of asymptomaticchronic HIV infection: the calm before the storm[ J]. Curr Opin HIVAIDS, 2009, 4(3) ;206-214.
  • 6Alexandra S, Claire D, Irini S, et al. Initiation of ART during earlyacute HIV infection preserves mucosal Thl7 function and reversesHIV-related immune activation [J/OL]. PLoS Pathog, 2014,10(12): el004543. doi: 10. 1371/joumal. ppat. 1004543.eCollection 2014.
  • 7Ananworanich J, Sacdalan C P, Pinyakom S, et al. Virological andimmunological characteristics of HIV-infected individuals at theearliest stage of infection[ J] . J Virus Erad, 2016,2(2) : 43 -48.
  • 8Zdrenghea M T, Johnston S L. Role of PD-L1/PD-1 in the immuneresponse to respiratory viral infections [ J ]. Microbes Infect, 2012,14(6) : 495 -499.
  • 9Bertram B, Bianca S, Marianne R, et al. Coexpression of PD-1,2B4, CD160 and KLRG1 on exhausted HGV-specific CD8 + T cellsis linked to antigen recognition and T cell differentiation [ J/OL ] .PLoS Pathog, 2010,6(6) : el000947. doi: 10.1371/joumal. ppat.1000947.
  • 10Viganb S, Banga R, Bellanger F, et al. CD160-associated CD8T-cell functional impairment is independent of PD-1 expression [ J ] .PLoS Pathog, 2014, 10(9): el004380. doi: 10. 1371/joumal.ppat. 1004380. eCollection 2014.

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部